Research / KSCP / Fundamental state Inspectable configuration
State dimensions Filing 0001410578-24-000417 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
9.71% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 75th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.57% · OPTIONAL · VALID
Operating cash generation 88th Own-history percentile · N=8
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-188.76% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
127.26% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
18.13% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin 67th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.gross_margin
-15.82% · CORE · VALID
Operating margin 78th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.operating_margin
-205.42% · CORE · VALID
R&D intensity 22th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
49.63% · OPTIONAL · VALID
SBC intensity 22th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
21.30% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/5 normalized Level 3 Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/6 normalized Level 3 Jun 30, 2022 0/6 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 4/9 normalized Level 3 Dec 31, 2023 6/9 normalized Level 3 Mar 31, 2024 5/7 normalized Level 3 Jun 30, 2024 5/7 normalized Level 3 Sep 30, 2024 7/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 8.21%
Current 9.71%
Delta 1.49% Capex Intensity Increased
Previous -0.09%
Current 3.57%
Delta 3.66% Cash Generation Increased
Previous -208.87%
Current -188.76%
Delta 20.12% Growth Decreased
Previous 156.48%
Current 127.26%
Delta -29.22% Inventory Pressure Decreased
Previous 95.04%
Current 18.13%
Delta -76.91% Margin Decreased
Previous 1.50%
Current -15.82%
Delta -17.32% Profitability Decreased
Previous -195.04%
Current -205.42%
Delta -10.39% R And D Intensity Decreased
Previous 57.25%
Current 49.63%
Delta -7.62% Sbc Intensity Decreased
Previous 25.36%
Current 21.30%
Delta -4.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.